216 related articles for article (PubMed ID: 21469125)
1. In vivo diabetogenic action of CD4+ T lymphocytes requires Fas expression and is independent of IL-1 and IL-18.
Wen L; Green EA; Stratmann T; Panosa A; Gomis R; Eynon EE; Flavell RA; Mezquita JA; Mora C
Eur J Immunol; 2011 May; 41(5):1344-51. PubMed ID: 21469125
[TBL] [Abstract][Full Text] [Related]
2. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
[TBL] [Abstract][Full Text] [Related]
3. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
Redd S; Ginn S; Ross JM
Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.
Kim S; Kim KA; Hwang DY; Lee TH; Kayagaki N; Yagita H; Lee MS
J Immunol; 2000 Mar; 164(6):2931-6. PubMed ID: 10706679
[TBL] [Abstract][Full Text] [Related]
5. Fas/Fas ligand interactions play an essential role in the initiation of murine autoimmune diabetes.
Nakayama M; Nagata M; Yasuda H; Arisawa K; Kotani R; Yamada K; Chowdhury SA; Chakrabarty S; Jin ZZ; Yagita H; Yokono K; Kasuga M
Diabetes; 2002 May; 51(5):1391-7. PubMed ID: 11978635
[TBL] [Abstract][Full Text] [Related]
6. Significant role for Fas in the pathogenesis of autoimmune diabetes.
Su X; Hu Q; Kristan JM; Costa C; Shen Y; Gero D; Matis LA; Wang Y
J Immunol; 2000 Mar; 164(5):2523-32. PubMed ID: 10679090
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
Christianson SW; Shultz LD; Leiter EH
Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic mechanisms employed by mouse T cells to destroy pancreatic β-cells.
Varanasi V; Avanesyan L; Schumann DM; Chervonsky AV
Diabetes; 2012 Nov; 61(11):2862-70. PubMed ID: 22773667
[TBL] [Abstract][Full Text] [Related]
9. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.
Suarez-Pinzon W; Sorensen O; Bleackley RC; Elliott JF; Rajotte RV; Rabinovitch A
Diabetes; 1999 Jan; 48(1):21-8. PubMed ID: 9892218
[TBL] [Abstract][Full Text] [Related]
10. In vivo effects of cytokines on pancreatic beta-cells in models of type I diabetes dependent on CD4(+) T lymphocytes.
Angstetra E; Graham KL; Emmett S; Dudek NL; Darwiche R; Ayala-Perez R; Allison J; Santamaria P; Kay TW; Thomas HE
Immunol Cell Biol; 2009 Feb; 87(2):178-85. PubMed ID: 19015667
[TBL] [Abstract][Full Text] [Related]
11. IFN-γ receptor deficiency prevents diabetes induction by diabetogenic CD4+, but not CD8+, T cells.
Yi Z; Li L; Garland A; He Q; Wang H; Katz JD; Tisch R; Wang B
Eur J Immunol; 2012 Aug; 42(8):2010-8. PubMed ID: 22865049
[TBL] [Abstract][Full Text] [Related]
12. Fas and Fas ligand immunoexpression in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
Reddy S; Ross JM
Ann N Y Acad Sci; 2003 Nov; 1005():166-9. PubMed ID: 14679052
[TBL] [Abstract][Full Text] [Related]
13. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.
You S; Slehoffer G; Barriot S; Bach JF; Chatenoud L
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse.
Bobbala D; Chen XL; Leblanc C; Mayhue M; Stankova J; Tanaka T; Chen YG; Ilangumaran S; Ramanathan S
Diabetologia; 2012 Nov; 55(11):3010-20. PubMed ID: 22890824
[TBL] [Abstract][Full Text] [Related]
15. mt-Nd2(a) Modifies resistance against autoimmune type 1 diabetes in NOD mice at the level of the pancreatic β-cell.
Chen J; Gusdon AM; Piganelli J; Leiter EH; Mathews CE
Diabetes; 2011 Jan; 60(1):355-9. PubMed ID: 20980458
[TBL] [Abstract][Full Text] [Related]
16. Stable activity of diabetogenic cells with age in NOD mice: dynamics of reconstitution and adoptive diabetes transfer in immunocompromised mice.
Kaminitz A; Mizrahi K; Ash S; Ben-Nun A; Askenasy N
Immunology; 2014 Jul; 142(3):465-73. PubMed ID: 24601987
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
[TBL] [Abstract][Full Text] [Related]
18. The Presence and Preferential Activation of Regulatory T Cells Diminish Adoptive Transfer of Autoimmune Diabetes by Polyclonal Nonobese Diabetic (NOD) T Cell Effectors into NSG versus NOD-scid Mice.
Presa M; Chen YG; Grier AE; Leiter EH; Brehm MA; Greiner DL; Shultz LD; Serreze DV
J Immunol; 2015 Oct; 195(7):3011-9. PubMed ID: 26283479
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.
Silva DG; Petrovsky N; Socha L; Slattery R; Gatenby P; Charlton B
J Immunol; 2003 May; 170(10):4996-5002. PubMed ID: 12734343
[TBL] [Abstract][Full Text] [Related]
20. Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.
Balasa B; Van Gunst K; Jung N; Balakrishna D; Santamaria P; Hanafusa T; Itoh N; Sarvetnick N
J Immunol; 2000 Sep; 165(5):2841-9. PubMed ID: 10946317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
